市場調査レポート
商品コード
1499413
歯科用骨移植片・代替物市場:タイプ、製品、用途、エンドユーザー別-2024-2030年の世界予測Dental Bone Grafts & Substitutes Market by Type (Allograft, Alloplast, Synthetic Bone Graft), Product (Bio-OSS, Grafton, OsteoGraf), Application, End-User - Global Forecast 2024-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
歯科用骨移植片・代替物市場:タイプ、製品、用途、エンドユーザー別-2024-2030年の世界予測 |
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
|
歯科用骨移植片・代替物市場規模は、2023年に11億4,000万米ドルと推定され、2024年には12億2,000万米ドルに達し、CAGR 7.29%で2030年には18億7,000万米ドルに達すると予測されています。
歯科用骨移植片・代替物には、骨の成長を刺激し、骨欠損や骨喪失がある部位の骨再生を促進するために歯科外科で使用される製品や材料が含まれます。これらの製品の材料には、人骨、動物の骨、合成材料があります。歯周病、歯の喪失、口腔疾患の増加により、世界中の高齢者や成人人口の骨移植の必要性が高まっています。口腔衛生に対する意識の高まりや審美的な関心もまた、市場の成長に拍車をかけています。しかし、移植片や代用品に関連する高額な費用は、患者にとって法外なものとなる可能性があります。加えて、保険診療における歯科処置の適用範囲が限られていることも、市場の広がりを制限しています。組織工学と再生医療における技術革新は、移植片材料の選択肢と手順の強化に役立っています。さらに、3DプリンティングとAIの導入が増加しており、今後数年間で移植片と代替品の開発に新たな機会が生まれます。
主な市場の統計 | |
---|---|
基準年[2023] | 11億4,000万米ドル |
予測年[2024] | 12億2,000万米ドル |
予測年 [2030] | 18億7,000万米ドル |
CAGR(%) | 7.29% |
地域別洞察
南北アメリカは、高齢化人口の増加、健康に対する意識、低侵襲手術の嗜好などの普及により、歯科用骨移植片および代替品の十分な市場を有しています。ヒトや動物由来の製品への依存を減らすため、主にバイオマテリアルの研究や合成代替品の開発に重点を置いた投資が、この地域の市場を拡大させました。欧州諸国では、確立されたヘルスケアシステムと高い医療機器基準が市場の成長を支えています。同様に、欧州連合(EU)の厳しい規制環境は、製品の安全性と有効性を保証し、新しい技術に対する消費者の信頼に影響を与えています。中東は、医療ツーリズムの増加とヘルスケアインフラの改善により、歯科用骨移植片市場の成長を経験しています。アフリカ地域は、技術的進歩への新たな投資を伴う新興ヘルスケアセクターの成長が遅れており、市場成長の潜在的要素となり得る。APAC地域では、人口の増加、医療に対する政府の支援の拡大、高齢者の低侵襲手術への嗜好が、日本、中国、インドなどの国々における市場拡大の道を開いた。
FPNVポジショニング・マトリックス
FPNVポジショニングマトリックスは歯科用骨移植片・代替物市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、事業戦略や製品満足度に関連する重要な指標を調査します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront(F)、Pathfinder(P)、Niche(N)、Vital(V)に分類されます。
市場シェア分析
市場シェア分析は、歯科用骨移植片・代替物市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査対象期間の累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。
戦略分析と推奨
戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、歯科用骨移植片・代替物市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。
TABLE 318
[182 Pages Report] The Dental Bone Grafts & Substitutes Market size was estimated at USD 1.14 billion in 2023 and expected to reach USD 1.22 billion in 2024, at a CAGR 7.29% to reach USD 1.87 billion by 2030.
The dental bone grafts & substitutes include products and materials operated in dental surgery to stimulate bone growth and facilitate bone regeneration in areas with bone loss or deficiency. The source for the material of these products can be human bone, animal bone and synthetic material. Rising incidences of periodontal diseases, tooth loss, and oral ailments drive the need for bone graft procedures for the aged and adult population across the globe. Increased awareness about oral hygiene and aesthetic concerns also spur market growth. However, high cost associated with the grafts and substitutes can be prohibitive for patients. Additionally, limited coverage of dental procedures in the insurance sector restricts the spread of the market. Innovations in tissue engineering and regenerative medicine are helping in enhancing graft material options and procedures. In addition, rising incorporation of 3D printing and AI is creating new opportunity for the development of grafts and substitutes in the upcoming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.14 billion |
Estimated Year [2024] | USD 1.22 billion |
Forecast Year [2030] | USD 1.87 billion |
CAGR (%) | 7.29% |
Regional Insights
The Americas have a sufficient market for dental bone grafts and substitutes due to the prevalence of the increased aged population, awareness about health, and preference for minimally invasive surgeries. Investments primarily focused on biomaterial research and the development of synthetic alternatives to reduce dependency on human and animal-derived products expanded the market in the region. In European countries, well-established healthcare systems and high medical device standards support the market's growth. Similarly, the stringent regulatory environment of the European Union ensures that products are safe and effective, influencing consumer confidence in newer technologies. The Middle East is experiencing growth in the dental bone grafts market due to increasing medical tourism and improving healthcare infrastructure. African regions have slow emerging healthcare sectors with new investments in technological advancements, which can be a potential element for the growth of the market. In the APAC region, increased population growth, growing governmental support for healthcare, and an aged population's preferences for minimally invasive surgeries paved the way for the spread of the market in countries such as Japan, China, and India.
Market Insights
The market dynamics represent an ever-changing landscape of the Dental Bone Grafts & Substitutes Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Dental Bone Grafts & Substitutes Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Dental Bone Grafts & Substitutes Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
ZimVie Inc. Expanded Dental Implant Solutions in Japan with Launch of TSX Implant
ZimVie Inc., a life sciences company in dental and spine solutions, announced the release of the TSX Implant in Japan. The TSX Implant, known for its suitability for immediate use post-extraction and effectiveness in both soft and dense bone. The implant has features such as peri-implant health, consistent bone maintenance at the crestal level, durable osseointegration, and prosthetic stability. [Published On: 2024-02-07]
Innovations in Bone Healing as Renovos Biologics Limited BMP-2 Gained FDA Recognition
Renovos Biologics Limited has received FDA approval for Renovite BMP-2, a cutting-edge synthetic nanoclay gel infused with bone morphogenic protein 2 (BMP-2). Renovite BMP-2 serves as an alternative to traditional bone grafts, facilitating precise and targeted bone regeneration while preventing BMP-2 leakage. The gel is formulated to degrade naturally as new bone tissue forms, enhancing safety and efficacy. [Published On: 2024-01-04]
Strategic Expansion in Bone Regeneration Technologies as Biocomposites Ltd. Acquired Artoss, Inc.
Artoss, Inc., a company in advanced bone graft substitutes employing its unique NanoBone technology acquired by Biocomposites Ltd. company officials highlighted this acquisition as pivotal, enhancing their portfolio with innovative, ready-to-use products and strengthening their position in bone regeneration and infection management solutions in orthopedic care. [Published On: 2023-06-14]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Dental Bone Grafts & Substitutes Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Dental Bone Grafts & Substitutes Market, highlighting leading vendors and their innovative profiles. These include AlloSource, Baxter International Inc., BioHorizons, Inc, botiss biomaterials GmbH, Collagen Matrix, Inc., Dentium Co., Ltd, Dentsply Sirona, Geistlich Pharma AG, Hannox International Corp., immer Biomet Holdings, Inc., Institut Straumann AG, Integra LifeSciences Corporation, Johnson & Johnson, LIFENET HEALTH, INC., Maxigen Biotech Inc., Medtronic PLC, NovaBone Products, LLC by Halma plc, Orthofix Medical Inc., Osteogenics Biomedical, Inc., RTI Surgical, Inc., Stryker, and ZimVie Inc..
Market Segmentation & Coverage